Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Savitri Krishnamurthy

Showing results (231-240 of 262) with videos related to

Pageof 27
Sort By:
JAMA Surgery|April 20, 2017
Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary SurgeryAudree B Tadros, Wei T Yang, Savitri Krishnamurthy, et al.
British Journal of Cancer|May 17, 2024
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancerWarapen Treekitkarnmongkol, Vandna Shah, Kazuharu Kai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to ChemotherapyToshiaki Iwase, Evan N Cohen, Hui Gao, et al.
Annals of Surgery|July 26, 2017
Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast ConservationAudree B Tadros, Benjamin D Smith, Yu Shen, et al.
Cancer|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.
Cancer|June 5, 2003
Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinomaW Fraser Symmans, Mark Ayers, Edwin A Clark, et al.
Molecular Cancer Therapeutics|May 13, 2025
Inhibition of MCL-1 and MEK overcomes MEK inhibitor resistance in triple-negative and inflammatory breast cancersMohd Mughees, Moises J Tacam, Alex W Tan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2026
Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: A prospective, phase II trialSimona F Shaitelman, Savitri Krishnamurthy, Heather Lin, et al.
Cancer Immunology Research|May 3, 2019
Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast CancerSangeetha M Reddy, Alexandre Reuben, Souptik Barua, et al.
Pageof 27

Showing results (231-240 of 262) with videos related to

Sort By:
Pageof 27
JAMA Surgery|April 20, 2017
Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary SurgeryAudree B Tadros, Wei T Yang, Savitri Krishnamurthy, et al.
British Journal of Cancer|May 17, 2024
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancerWarapen Treekitkarnmongkol, Vandna Shah, Kazuharu Kai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to ChemotherapyToshiaki Iwase, Evan N Cohen, Hui Gao, et al.
Annals of Surgery|July 26, 2017
Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast ConservationAudree B Tadros, Benjamin D Smith, Yu Shen, et al.
Cancer|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.
Cancer|June 5, 2003
Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinomaW Fraser Symmans, Mark Ayers, Edwin A Clark, et al.
Molecular Cancer Therapeutics|May 13, 2025
Inhibition of MCL-1 and MEK overcomes MEK inhibitor resistance in triple-negative and inflammatory breast cancersMohd Mughees, Moises J Tacam, Alex W Tan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2026
Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: A prospective, phase II trialSimona F Shaitelman, Savitri Krishnamurthy, Heather Lin, et al.
Cancer Immunology Research|May 3, 2019
Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast CancerSangeetha M Reddy, Alexandre Reuben, Souptik Barua, et al.
Pageof 27